Efficacy of Adductor Canal Block for Anterior Cruciate Ligament Surgery (DUAL)

St. Antonius Hospital

Status: Completed

Conditions: Anterior Cruciate Ligament Injuries

Treatments: Procedure: Adductor canal block; Drug: Placebo; Drug: Levobupivacaine

Study type: Interventional

Funder types: Other

Identifiers

NCT05532618

NL 81489.100.22

Details and patient eligibility

About

The goal of this study is to objectify the postoperative pain level, the use of opiates and postoperative nausea and vomiting after adding the adductor canal block to the standard pain regiment after anterior cruciate ligament surgery

Full description

Patients scheduled for anterior cruciate ligament surgery will be randomized in an intervention and control group following informed consent.

Before surgery, patients will receive an adductor canal bock with Levobupivacaine (intervention group) or 0.9% saline (control group).

Following surgery, pain intensity, analgesic consumption and pain satisfaction will be recorded bij patients in a diary for 48 hours.

Enrollment: 34 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age 18 or older
• Undergoing anterior cruciate ligament surgery under general anesthesia
• ASA I-III

Exclusion criteria

• Contraindication for locoregional anesthesia; infection at the target puncture site, allergy to local anesthetics,
• Neuromuscular disorders

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

34 participants in 2 patient groups, including a placebo group

Levobupivacaine

Active Comparator group

Description:

Intervention group; 10 ml of Levobupivacaine 0.25% will be added in the adductor canal using ultrasound

Treatment:

Procedure: Adductor canal block

Drug: Levobupivacaine

Placebo

Placebo Comparator group

Description:

Control group; 10 ml of sodium chloride 0.9% will be added in the adductor canal using ultrasound

Treatment:

Procedure: Adductor canal block

Drug: Placebo